UnitedHealth Group (NYSE:UNH) PT Raised to $562.00

UnitedHealth Group (NYSE:UNH) had its target price lifted by analysts at Deutsche Bank Aktiengesellschaft from $545.00 to $562.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 13.96% from the company’s current price.

UNH has been the subject of a number of other reports. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. Finally, Oppenheimer reissued an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Up 3.0 %

NYSE:UNH opened at $493.16 on Friday. The firm has a market cap of $454.66 billion, a P/E ratio of 30.14, a P/E/G ratio of 1.31 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a 50-day simple moving average of $488.97 and a two-hundred day simple moving average of $515.22.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the business earned $6.26 EPS. Analysts predict that UnitedHealth Group will post 27.74 earnings per share for the current fiscal year.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in UNH. Moneta Group Investment Advisors LLC lifted its position in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $5,802,231,000. Arrowstreet Capital Limited Partnership lifted its position in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of UnitedHealth Group by 143.4% during the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after acquiring an additional 2,058,829 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.